Search results
Results From The WOW.Com Content Network
Incidence is usually more useful than prevalence in understanding the disease etiology: for example, if the incidence rate of a disease in a population increases, then there is a risk factor that promotes the incidence. For example, consider a disease that takes a long time to cure and was widespread in 2002 but dissipated in 2003.
Lifetime prevalence (LTP) is the proportion of individuals in a population that at some point in their life (up to the time of assessment) have experienced a "case" (e.g., a disease, a traumatic event, or, a behavior, such as committing a crime). Often, a 12-month prevalence (or some other type of "period prevalence") is provided in conjunction ...
This task requires the forward-looking ability of modern risk management approaches that transform health risk factors, incidence, prevalence and mortality statistics (derived from epidemiological analysis) into management metrics that not only guide how a health system responds to current population health issues but also how a health system ...
Epidemiological (and other observational) studies typically highlight associations between exposures and outcomes, rather than causation. While some consider this a limitation of observational research, epidemiological models of causation (e.g. Bradford Hill criteria) [7] contend that an entire body of evidence is needed before determining if an association is truly causal. [8]
The notable unsolved problems in statistics are generally of a different flavor; according to John Tukey, [1] "difficulties in identifying problems have delayed statistics far more than difficulties in solving problems." A list of "one or two open problems" (in fact 22 of them) was given by David Cox. [2]
From a mathematical point of view, by taking values between 0 and 1 or 0% and 100%, CFRs are actually a measure of risk (case fatality risk) – that is, they are a proportion of incidence, although they do not reflect a disease's incidence. They are neither rates, incidence rates, nor ratios (none of which are limited to the range 0–1). They ...
The average lifetime prevalence found was 6.7% for MDD (with a relatively low lifetime prevalence rate in higher-quality studies, compared to the rates typically highlighted of 5–12% for men and 10–25% for women), and rates of 3.6% for dysthymia and 0.8% for Bipolar 1. [18]
Lessler and others suggest that a hyperendemic region or synonymously a "burden hotspot" (defined as an area of elevated disease incidence or prevalence) should be distinguished from an "emergence hotspot" (defined as an area with a high frequency of emergence or reemergence of diseases or drug-resistant strains) and a "transmission hotspot ...